Maipu Medical Acquires Yijie Medical for $335 Million: Leading Neuro-Implant Cross-Field Intervention

Maipu Medical, a leading neurosurgical implant device company, disclosed a revised restructuring proposal on May 25th. The company plans to purchase 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. for approximately $335 million through a combination of share issuance and cash payment. Yijie Medical, established in 2020, focuses on neuro intervention products, including catheters, balloons, guide wires, and stents. The acquisition allows Maipu Medical to expand its business from neurosurgical implants to minimally invasive neuro-intervention, tapping into the domestic multi-billion-dollar neuro-intervention market.